Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
AuthID
P-00H-893
P-00H-893
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service